PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,124,000 | -51.0% | 58,965 | -28.7% | 0.01% | -54.5% |
| Q4 2015 | $6,371,000 | +1836.5% | 82,720 | +934.0% | 0.01% | +1000.0% |
| Q3 2015 | $329,000 | -91.6% | 8,000 | -81.9% | 0.00% | -85.7% |
| Q1 2015 | $3,926,000 | -52.2% | 44,195 | -52.4% | 0.01% | -50.0% |
| Q4 2014 | $8,210,000 | -17.7% | 92,842 | -9.8% | 0.01% | -22.2% |
| Q3 2014 | $9,974,000 | -11.0% | 102,911 | -15.7% | 0.02% | -10.0% |
| Q2 2014 | $11,213,000 | +39.5% | 122,071 | +6.3% | 0.02% | +42.9% |
| Q1 2014 | $8,036,000 | +59.2% | 114,827 | +55.3% | 0.01% | +55.6% |
| Q4 2013 | $5,048,000 | +74.8% | 73,959 | +23.2% | 0.01% | +80.0% |
| Q3 2013 | $2,888,000 | +76.9% | 60,046 | +6.6% | 0.01% | +66.7% |
| Q2 2013 | $1,633,000 | – | 56,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |